Jacqueline Sara Jeruss MD
Breast, Surgical Oncology (Other than Breast)
Assistant Professor in Surgery-Surgical Oncology, Northwestern University Medical School
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Jeruss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Surgery, 1997 - 2005
- University of Vermont College of MedicineClass of 1997
Certifications & Licensure
- MI State Medical License 2014 - 2027
- IL State Medical License 1997 - 2017
- TX State Medical License 2005 - 2006
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- The Effectiveness of Superparamagnetic Iron Oxide Nanoparticles in Reducing Unnecessary Sentinel Lymph Node Biopsies.Erin Kim, Lesly A Dossett, Tasha M Hughes, Jacqueline S Jeruss, Michael S Sabel
Annals of Surgical Oncology. 2025-03-13 - Design Principles of an Engineered Metastatic Niche for Monitoring of Cancer Progression.Guillermo Escalona, Ramon Ocadiz-Ruiz, Jeffrey A Ma, Ian A Schrack, Brian C Ross
Biotechnology and Bioengineering. 2025-03-01 - Psychological Considerations Associated with Lobular Breast Cancer.Jasmine C Walker, Shivali Patel, Erin F Cobain, Celina G Kleer, Colleen H Neal
Current Psychiatry Reports. 2025-02-01
Press Mentions
- New Tests and Devices for Early Cancer DetectionApril 1st, 2020
- Drug Combo Gangs up to Take on Triple-Negative Breast CancerOctober 25th, 2017
- Pink Beer on Tap as Ann Arbor Businesses Support Breast Cancer CampaignOctober 18th, 2017
- Join now to see all
Grant Support
- Nanoparticles to reprogram innate immune cells and disrupt the metastatic nicheUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
- Tissue engineering tools for monitoring the cellular and molecular response to therapyUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2028
- University of Michigan Surgical Oncology Research Training ProgramUNIVERSITY OF MICHIGAN AT ANN ARBOR1991–2027
- Identifying intercellular circuits driving cell phenotypes within a nicheUNIVERSITY OF MICHIGAN AT ANN ARBOR2019–2025
- The Oncogenic Significance Of Cyclin Overexpression And SMAD 3 Tumor SuppressionNational Cancer Institute2011
- The Oncogenic Significance Of Cyclin Overexpression And SMAD 3 Tumor SuppressionNational Cancer Institute2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: